Wilmar Cahaya Indonesia Tbk.

Rating: Underweight

Executive Summary: Untuk CEKA.JK: alokasi baru = 0, dan eksposur yang sudah ada dipangkas bertahap menuju maksimum 1/3 unit standar (atau batas risiko portofolio Anda bila lebih rendah). Jangan pasang order pasar—rata-rata print ~1.000 saham per transaksi dengan turnover normal ~Rp50 juta/hari—pakai limit pasif tersebar beberapa sesi, maksimal 10-15% volume harian teramati per order, mulai dari tranche kecil di 2.200-2.240 dan sisanya ke kekuatan di 2.264-2.292. Close di bawah 2.080 memicu de-risking tambahan bertahap, dan close di bawah 1.920 menginvalidasi sisa posisi; jangan short CEKA.JK. Horizon 1-3 bulan, dengan syarat re-entry yang harus dipenuhi semua sebelum menaikkan kembali ke Hold/Overweight.

Investment Thesis: Kubu bear menang pada isu yang paling menentukan: investabilitas dan timing masuk, bukan kerusakan usaha. Tiga bukti mengikat. Pertama, argumen "penyerapan oleh uang besar" gugur secara kuantitatif: net buy broker YU/NI hanya sekitar Rp165 juta (angka gabungan yang benar, bukan Rp165 miliar), XL adalah Stockbit yang retail-heavy, sementara tape 2026-10-27 hanya Rp404,9 juta pada volume 7,7x normal—artinya aliran "institusional" itu terlalu kecil untuk mengubah struktur pasar di likuiditas ~Rp50 juta/hari. Feed accumulation history kosong dan order flow nol tick, jadi follow-through tidak bisa diverifikasi. Kedua, risk/reward baru negatif: upside ke resistance stack (SMA200 2.264,2; high 2.270; Bollinger upper 2.292,5) hanya sekitar 4-6,6%, sedangkan invalidasi 1.920 berarti 10,7-12,5% downside, belum termasuk slippage di saham dengan ATR 98,3 (4,5%) dan free float ~14%—float tipis di sini bukan margin of safety, melainkan pengganda slippage. Ketiga, konfirmasi tren tidak ada: CEKA.JK masih di bawah SMA200 2.264,2, MACD line -15,89 (histogram positif hanya berarti downtrend melambat), dan candle 2026-10-27 menolak di 2.270 lalu kembali ke open setelah rebound 14,6% dalam enam sesi—itu churn, bukan akumulasi. Pressure jual CC (4 dari 5 hari) dan YP (5 dari 5 hari) belum selesai.

Saya juga menolak dua penyederhanaan. (a) Valuasi 8,7x adalah annualisasi H1 2026 yang belum terverifikasi; dengan gross margin 5,1% dan net margin 2,7%, laba sangat sensitif terhadap CPO, rupiah, dan kebijakan domestik, sementara balance sheet, arus kas operasi, working capital, dan kebijakan dividen tidak tersedia—jadi "murah" tidak boleh diperlakukan sebagai margin of safety. Insider selling Sentratama (~100.000 saham, ~0,017% float, di 2.400-2.620) magnitudes-nya kecil dan bukan alasan utama, tetapi arah dan timing-nya sejalan dengan distribusi harga. (b) Namun sisi bull tetap valid pada hal-hal yang mencegah Sell penuh: H1 2026 laba Rp75,4 miliar, harga masih di atas EMA10 2.128 dan SMA50 2.172,6, RSI 55,5 netral, kepemilikan pengendali 86% memberi stabilitas jangka panjang, dan likuiditas tipis membuat likuidasi paksa justru merusak nilai—rekan konservatif benar bahwa exit risk dan gap risk lebih besar daripada risiko downside linear yang dipakai rekan agresif.

Karena itu bobot keputusan ada di antara Sell dan Reduce, dan saya condong ke Reduce (Underweight): arahnya jelas bearish pada eksposur baru (nol) dan pada pemangkasan, tetapi tidak sampai keluar total atau short. Kerangka eksekusi mengikuti rekan netral, bukan rekan agresif: "jual ke kekuatan di 2.264-2.292" saja berisiko limit tidak terisi sementara posisi tetap overexposed, jadi sebagian kecil dipotong lebih awal di 2.200-2.240 dengan limit pasif. Syarat kenaikan rating (semua harus terpenuhi): (a) close di atas 2.292,5 dengan volume minimal setara sesi 2026-10-27 dan bertahan 3-5 sesi di atas baseline baru (bukan harus kembali ke baseline lama 24K saham/hari); (b) CC dan YP berhenti menjual tiga sesi berturut-turut; (c) balance sheet, arus kas operasi, dan working capital tersedia serta menunjukkan posisi kas/utang sehat. Yang berubah pikiran ke arah bear penuh: close di bawah 1.920. Yang membatalkan tesis bear: breakout terkonfirmasi di atas 2.292,5 dengan volume berlanjut plus tekanan jual broker mereda. Data yang tetap terbuka dan tidak boleh diasumsikan: neraca, laporan arus kas, kebijakan dividen, riwayat akumulasi, order flow; tape 2026-10-27 bersifat intraday dan angka 36 lot/Rp7,9 juta pada laporan fundamental tidak sinkron dengan tape, sehingga laporan itu hanya indikatif.

Price Target: 2264.0

Time Horizon: 1-3 bulan

Action: Sell

Reasoning: The Underweight case for CEKA.JK wins on investability, not on business collapse. At 2,200, CEKA.JK is jammed under the resistance stack of SMA200 2,264.2, the 2026-10-27 high 2,270, and Bollinger upper 2,292.5 after a 14.6% six-session rebound. The session showed rejection at the highs and a close back at the open on 7.7× abnormal volume, which is churn/two-way battle, not confirmed accumulation. MACD remains negative at -15.89 and price is still below SMA200, so the positive histogram only says the downtrend is decelerating. Risk/reward for new exposure is poor: buying 2,080–2,150 would front-run the plan’s own confirmation levels, while invalidation below 1,920 implies more downside than the upside to 2,292.5. Liquidity is the dominant constraint: normal turnover is only around Rp50M/day, so slippage can consume the thesis. Broker “institutional” buying is small relative to turnover, includes retail-heavy Stockbit flow, and persistent sellers CC/YP remain unresolved. Missing balance sheet, cash flow, working capital, dividend policy, accumulation-history, and order-flow data mean follow-through and earnings quality cannot be verified. The bull points—H1 2026 profit, non-demanding annualized P/E, 86% controlling shareholder, and price above EMA10/SMA50 with neutral RSI—argue against a forced full liquidation or short, but not for new or maintained full exposure. For CEKA.JK, reduce rather than add.

Entry Price: Not applicable for a new long; new allocation is 0. For reducing existing CEKA.JK, work sell limits into strength at 2,264–2,292; do not chase exits below 2,080. Re-entry is not justified until CEKA.JK closes above 2,292.5 on volume at least equal to 2026-10-27, CC/YP stop selling for three consecutive sessions, and balance sheet/cash flow/working-capital data are verified.

Stop Loss: For any residual CEKA.JK holding, a close below 1,920 invalidates the remaining recovery thesis and should trigger exit of the residual. The 2,080 area is a monitoring level, not a stop. Do not use a tight market stop in this illiquid tape, and do not short CEKA.JK.

Position Sizing: New CEKA.JK allocation is 0. Existing exposure should be reduced to no more than 1/3 of a standard unit. Execute reductions in staged limit orders into 2,264–2,292, with each order no more than 10–15% of observed daily volume and spread across multiple sessions; avoid market orders entirely. If the book is flat, do nothing except avoid initiating CEKA.JK.

Recommendation: Underweight

Rationale: Saya menimbang kedua sisi dan kubu bear menang pada isu yang paling menentukan, meski tidak menang mutlak. Poin yang memutuskan adalah koreksi satuan pada data flow. Bull membangun argumen "bid institutional-looking" sekitar Rp165 miliar dari angka broker YU/NI/PD, padahal tape hari itu hanya Rp404,9 juta — jadi neto broker yang sebenarnya berkisar Rp165-182 juta, sekitar 0,01% kapitalisasi pasar. Bull sendiri akhirnya mengakui kekeliruan serupa pada volume normal (Rp50 juta, bukan Rp50 miliar). Artinya argumen penyerapan distribusi oleh "uang besar" tidak punya dasar sama sekali, dan itu adalah tulang punggung sisi bullish di luar valuasi. Tanpa itu, yang tersisa hanya valuasi murah dan kepemilikan Wilmar.Benang kedua yang mengikat: hitungan risk/reward bull tidak bekerja. Dari entry 2.150 ke 2.292 upside sekitar 6,6%, sementara downside ke invalidasi 1.920 sekitar 10,7%, belum termasuk slippage di saham yang rata-rata print-nya sekitar 1.000 saham per transaksi. Bull juga menyerahkan sendiri bahwa ia akan menunggu jika close di bawah 2.080 dan baru menambah jika close di atas 2.292,5 — jadi rencananya adalah membeli sebelum sinyal yang ia sendiri sebut sebagai syarat konfirmasi. Itu front-running, bukan akumulasi terdisiplin. Ditambah harga masih di bawah SMA200 2.264,2, doji ber-upper shadow setelah rebound 14,6%, dan MACD line masih -15,89 (histogram positif hanya berarti downtrend melambat), tidak ada konfirmasi uptrend untuk dijadikan pijakan menambah eksposur.Benang ketiga: kualitas laba dan neraca belum terverifikasi. P/E 8,7x adalah hasil annualisasi H1 yang bull sendiri akui optimistis; skenario konservatifnya memberi 10,9x — untuk refiner dengan marjin bruto 5,1% dan marjin bersih 2,7%, itu bukan murah yang aman ketika balance sheet, arus kas, dan kebijakan dividen tidak tersedia. Di bisnis marjin 2,7%, working capital dan kualitas neraca adalah segalanya, dan justru itu yang kosong. Feed akumulasi dan order flow juga kosong, jadi durasi dan follow-through dari net buy hari itu tidak bisa diverifikasi. Insider selling 15 transaksi magnitudes-nya kecil (sekitar 100.000 saham, ~0,017% float) — di sini bull benar dan saya tidak memakainya sebagai alasan bear — tetapi timing 2.400-2.620 tetap searah dengan arah harga, bukan berlawanan.Sisi bull yang tetap saya hargai: perusahaan mencetak laba H1 2026 (Rp75,4 miliar), valuasi ekuitas tidak menuntut ekspektasi heroik, pemegang saham pengendali 86% memberi stabilitas kepemilikan jangka panjang, dan harga masih di atas EMA10 2.128 serta SMA50 2.172,6 dengan RSI 55,5 netral. Itu cukup untuk menolak kesimpulan "jual semua sekarang" dan cukup untuk tidak menyebut bisnisnya rusak. Karena itu saya tidak memberi Sell penuh: tesis bear di sini pada dasarnya adalah soal investabilitas dan timing masuk, bukan deteriorasi usaha, dan likuiditas yang tipis membuat exit paksa justru merusak nilai. Tetapi kombinasi likuiditas Rp50 juta/hari, flow institusional yang ternyata 1.000x lebih kecil dari klaim, risk/reward yang negatif, tren yang belum terkonfirmasi, dan data neraca yang tidak bisa diverifikasi membuat tesis bull belum memenuhi ambang untuk mendapat eksposur baru. Kesimpulannya: Underweight — jangan tambah, kurangi ke ukuran residual, dan biarkan bukti yang datang menentukan apakah ini layak dinaikkan lagi.

Strategic Actions: Sizing terhadap alokasi standar (1 unit = bobot normal satu nama di portofolio): CEKA.JK diturunkan ke maksimum 1/3 unit, dan alokasi baru untuk inisiasi adalah 0. Jangan ada pembelian di 2.080-2.150 sesuai usulan bull; itu zona tanpa konfirmasi dan dengan risk/reward negatif.Untuk posisi yang sudah ada: lakukan pengurangan bertahap menuju ≤1/3 unit, dan lakukan hanya ke kekuatan, memakai limit order di area 2.264-2.292 (SMA200 2.264,2 dan Bollinger upper 2.292,5). Hindari market order sepenuhnya — rata-rata print harian sekitar 1.000 saham per transaksi dan turnover normal sekitar Rp50 juta/hari, jadi slippage bisa memakan seluruh selisih tesis. Pecah order maksimal 10-15% dari volume harian yang teramati dan sebar di beberapa sesi; jangan pernah menyelesaikan exit dalam satu hari.Stop/invalidasi: penutupan di bawah 1.920 membatalkan sisa tesis keseluruhan — keluar dari residual tanpa menunggu pantulan. Zona 2.080 bukan stop, hanya level tontonan.Syarat untuk menaikkan kembali ke Hold/Overweight (semua harus terpenuhi, bukan sebagian): (a) penutupan di atas 2.292,5 dengan volume minimal sebesar sesi 2026-10-27; (b) broker CC dan YP berhenti menjual selama tiga sesi berturut-turut; (c) data balance sheet, arus kas operasi, dan working capital tersedia dan menunjukkan posisi kas/utang yang sehat. Sampai (c) ada, setiap kenaikan posisi ditolak berapa pun sinyal teknikalnya.Data yang hilang dan harus dinyatakan terbuka, bukan diasumsikan: neraca, laporan arus kas, kebijakan dividen, feed riwayat akumulasi, dan order flow. Jangan mengisi kekosongan itu dengan asumsi net cash atau "cash-generative". Catat juga bahwa tape 2026-10-27 bersifat intraday, bukan penutupan final, dan angka 36 lot/Rp7,9 juta pada laporan fundamental tidak sinkron dengan tape — gunakan tape terverifikasi dan perlakukan laporan fundamental sebagai indikatif saja.Untuk tim: perlakukan CEKA.JK sebagai posisi illiquid yang sedang dalam proses pengurangan, bukan ide baru. Tidak ada penambahan, tidak ada averaging down, dan tidak ada klaim "squeeze float tipis" sampai ada bukti follow-through.

Data integrity flags (read these first)

Three problems, which changed how I built this note:

1. Stale snapshot. My first call requested curr_date=2025-01-01 and returned rows ending 2024-12-30. The broker, accumulation and vendor feeds all run to 2026-10-27. I re-pulled at the live date; everything below is from the 2026-10-27 verification. The 2024 data should be ignored entirely.
2. Intraday, not a close. The market breadth feed reports status: open, Sesi 1 (09:00–12:00 WIB). So the "close" of 2,200 in today's row is the last traded price of an unfinished session, not a settled close. Any candle-pattern read is provisional.
3. Two empty feeds. get_accumulation_history returned no rows, and get_order_flow_detail returned 0 ticks. So I cannot confirm whether today's buying is a one-day event or part of a campaign, and I cannot see whether the session was bought or sold at the close. Treat those as unknowns, not as neutral evidence.

What the verified tape actually shows

The shape of the move matters more than the +2.80%. From the 2,180 close on 2026-10-15 the stock collapsed to 1,920 on 2026-10-19 (−11.9% in two sessions), then rallied six straight sessions back to 2,200 (+14.6% off the low). Today it traded a 190-point range (8.9%), tagged 2,270, sold back to 2,080, and ended exactly at the open. Long lower shadow (dip buyers) and rejection at 2,270, closing mid-range on 7.7× volume — that is churn/two-way battle, not clean accumulation.

Structure: price is above EMA10 (+3.4%) and SMA50 (+1.3%) but below SMA200 (−2.8%). MACD line is still negative at −15.89; the positive histogram is the downtrend decelerating, not an uptrend confirmed.

The point almost all of this analysis misses: liquidity

183,800 shares across 185 transactions, Rp 404.9 M turnover. The vendor's own 20-day average volume is ~24K shares/day (~Rp 50M) — today is a 7.7× anomaly. Average print size today was ~1,000 shares.

At this liquidity, a Rp 50–100M position is a material share of a normal day's turnover. Entry and exit slippage, not direction, is the dominant risk. A "2% stop" is not achievable here; a stop at 1,993 sits 2.1 ATR away on a stock that just fell 12% in two days and has daily ATR of 4.5%. It would plausibly be taken out by noise alone — and the 2026-10-19 low of 1,920 is below it, meaning that stop was already violated six sessions ago.

Broker flow: real, but read the counterparties

Two caveats on the bull case here. First, XL is Stockbit — retail order flow. Framing the buy side as "heavy buyer / smart money" overstates it; the genuinely institutional-looking names are YU and NI, worth ~Rp 165M combined. Second, the accumulation levels are at or above today's price (YU avg 2,195, XL 2,214, NI 2,165) — these buyers are at market, not at a discount. If 2,080–2,100 gives way, that cohort is underwater and becomes the next supply.

Against the buys: CC and YP are persistent sellers per the vendor (CC selling 4 of 5 days, YP 5 of 5). That's distribution into strength, and I can't verify its duration because the accumulation-history endpoint is empty.

Where I differ from the vendor

Agreement: mixed signal, no breakout yet, don't chase. Score 55/75 "WATCH" is a fair characterization.

Three disagreements:

• "Histogram POSITIF → Bullish trend." I weight this as neutral-to-weak. MACD at −15.89 is below zero, and price is below SMA200. Momentum is improving off a washout low; the trend is not up.
• Stop loss at 1,993. As argued above, this is inside the volatility envelope (2.1 ATR, above the 1,920 print from six sessions ago). If holding, the honest invalidation is a close below 1,920, i.e. a failed recovery — with a smaller position to compensate, not a tighter stop.
• Volume surge framed as purely bullish. 7.7× volume on a doji that closed where it opened is equally consistent with distribution into the bounce. Without tick data I can't distinguish, so I won't score it bullish.

My stance

No new long at 2,200. Not because the setup is bearish, but because the risk/reward is poor at this exact price: price is jammed between SMA50 (2,173) support and a resistance stack of SMA200 2,264 → today's high 2,270 → BB upper 2,292, immediately after a 14.6% six-session run, on an unfinished session showing rejection at the highs, in a stock that trades Rp 50M a day. A doji at resistance after a vertical bounce is where you wait, not where you commit.

If already holding: the trend thesis only survives above 2,080. The recovery is intact while price holds EMA10/2,128 on a closing basis; a close under 2,080 breaks today's low and puts 1,995 (BB lower) and 1,920 back in play. Size for the ATR, not for a 2% stop.

What would make me constructive:

• A daily close above 2,292 (BB upper) — clears the SMA200 and the resistance stack in one move, with volume ≥ today's.
• CC/YP stopping their selling for 3+ consecutive sessions — the flow would then be one-directional rather than a swap.
• Order-flow confirmation: large prints lifting the offer into the close. That feed is currently empty; I'd want it before trusting the bounce.
• Volume normalizing above the old 24K baseline rather than reverting to it — a one-day 7.7× spike with no follow-through is a liquidity event, not a re-rating.

What makes me bearish: a close below 2,080 with today's net buyers trapped above, or CC/YP continuing while the retail/foreign bid fades.

CEKA.JK — Wilmar Cahaya Indonesia Tbk.

Data note first: The statement endpoints (get_balance_sheet, get_cashflow, get_income_statement) returned only file-listing metadata across both quarterly and annual frequencies — no numbers. Seasonality also returned nothing (insufficient history). So this analysis rests on the fundamentals snapshot (latest: Q2 2026), insider filings, and quote data. Balance sheet, cash flow, and multi-year trend work could not be verified.

1. What the numbers actually say

Valuation: 595M shares × IDR 2,200 = IDR 1,309 bn market cap. Annualising H1 net income (IDR 150.8 bn) gives EPS ≈ IDR 253 → P/E ≈ 8.7x.

The margin structure is the whole story: 5.1% gross, 2.7% net. This is a CPO-refining spread business, not a branded-goods business. A 100bp move in the gross margin swings net income by roughly 40–50%. That makes earnings a leveraged bet on CPO input costs and rupiah-denominated selling prices — not something an 8.7x multiple on a single half-year is compensating you for. Be careful with the annualisation: refining spreads are seasonal and H2 has historically been the weaker half for Indonesian refiners, so IDR 151 bn is likely an optimistic run-rate.

2. The controlling shareholder is a persistent seller

Sentratama Niaga Indonesia (the Wilmar affiliate, ~511.7M of 595M shares ≈ 86%) has filed 15 consecutive SELL transactions since 20 May 2026, taking the stake from 511,774,700 down to 511,674,000.

Two things matter here, and they cut opposite ways:

• Magnitude is negligible — ~100K shares, roughly 0.017% of the float. This is a rounding error, not a distribution. It does not signal a loss of control conviction.
• Timing is not negligible — the June 22 block cleared at IDR 2,400–2,620, and the stock now prints 2,220. The insider sold into a local top and the price has since broken down ~11%. Price and insider direction are aligned downward in the near term.

3. The real problem: you cannot trade this

Turnover ratio 0.000309 — about 0.031% of shares changing hands daily. Today's session: 36 lots, IDR 7.9 million of value. Free float is ~14% (≈83M shares), of which the tradeable daily sliver is a rounding error.

This is the disqualifying fact, and it dominates everything else. At a P/E of 8.7x with a historically generous dividend policy, CEKA screens cheap on paper — but a position large enough to matter to a portfolio cannot be exited without moving the price against you for weeks. A paper valuation edge you cannot realise is not an edge. Note also the last_price of 2,220 sits above the 2,200 reference close with a VWAP of 2,202 — on 14 trades. That spread is noise, not information.

Verdict: NEUTRAL / AVOID new positions

Not because the business is bad — a cash-generative Wilmar-group refiner at ~9x is not expensive — but because:

1. Liquidity is prohibitive for any meaningful capital; this fails an investability screen before it reaches a valuation screen.
2. Earnings quality is thin-margin and volatile; the 8.7x is on an optimistic H1-annualised base with no balance sheet or cash flow data to confirm the quality of those earnings.
3. Insider direction and price trend are both negative (drip-selling from 2,400–2,620, now 2,220).

If you already hold it: there is no urgent reason to sell into 36-lot liquidity — you'd be the market. Treat it as a static, illiquid dividend holding and size any future add at a fraction of what the valuation would otherwise justify.

What would change this view:

• Sustained turnover above ~0.5% of shares/day (watch for a secondary offering or float expansion — the only realistic catalyst for liquidity).
• Verified FY2025 balance sheet showing a net-cash position, plus cash flow confirming net income converts to cash.
• Sentratama ceasing sales and price reclaiming the ~2,450–2,500 June shelf.

Data gaps to close before acting: FY2025 annual income statement/balance sheet/cash flow (all three endpoints failing), historical dividend payout, and any segment detail separating cooking oil from margarine/cocoa. Without those, the valuation call above is provisional.

Overall Sentiment: Neutral (Score: 5.0/10) Confidence: Low

Data Availability Disclosure (read first)

This report is not built on retrieved sentiment data. All three standard sources returned nothing usable in this session:

• News / financial media: no headlines, articles, or press releases retrieved for CEKA.JK.
• Social / retail forum chatter: no posts, message counts, or engagement metrics retrieved.
• Sell-side & broker commentary / flow data: no analyst notes, rating changes, or foreign/local flow statistics retrieved.

Because zero data points were collected, the Neutral band and 5.0 score below represent absence of signal, not a measured balance of opinion. They should be treated as a null result and refreshed with live feeds before any trade decision.

1. Source-by-Source Breakdown

No ratios, message counts, or notable posts can be cited because none were returned. Any specific figure I produced here would be fabricated.

2. Cross-Source Divergence and Alignment

Cannot be assessed. Divergence analysis requires at least two populated sources; here there are none. There is no alignment to report either — silence across all three channels is consistent only with low coverage, not with consensus.

3. Dominant Narrative Themes

No themes can be extracted from data. Two structural observations are worth carrying into the next refresh, stated as context rather than evidence:

• CEKA.JK (PT Wilmar Cahaya Indonesia Tbk) is a small-cap consumer staples name on IDX with thin free float and low sell-side coverage, which structurally explains sparse sentiment data. Expect small absolute message counts even on a healthy pull — this makes ratio-based readouts noisy.
• As an edible-oil / cocoa-derived products processor, its earnings narrative is mechanically tied to CPO and cocoa bean input costs, the IDR, and Indonesian domestic cooking-oil policy. These are the themes to test for — not themes confirmed by this data.

4. Catalysts and Risks

Unverified — no data support in this session:

• Upstream CPO and cocoa price direction, and any export levy or domestic price-ceiling policy shifts.
• FX (IDR/USD) moves affecting input cost and export realisation.
• Quarterly earnings release and any dividend declaration (the company has historically paid out, but timing and size are unconfirmed here).
• Liquidity risk: thin trading means order-book depth, not sentiment, may dominate short-horizon price action.

5. Key Sentiment Signals

Recommended Next Step

Re-run with live news search, IDX retail forum/Stockbit-style chatter, and broker flow before acting. Until then, treat any sentiment read on CEKA.JK — including this one — as uninformative.

Bottom line

I can't give you a view on CEKA.JK — the stock-specific data is genuinely unavailable right now. No quote, no volume, no news, and it does not appear in today's screener. Anything I said about its price action would be invented, so I won't.

Here's what I actually have, and what's missing.

Data availability

Two timing notes worth flagging: the screener run is stamped Selasa, 27 Oktober 2026 with a result age of ~86,400s (≈24 hours) — so it is yesterday's close-based run, not intraday, despite the "fresh" label. The breadth feed is intraday (Sesi 1, 09:00–12:00 WIB).

What the board does tell you

Market tone is soft and rotation is narrow. Of the top 10 by traded value, 7 are red — and it's the big liquid names leading down: TLKM −3.74%, ENRG −6.54%, BRPT −6.04%, BBRI −1.38%, BMRI −1.56%. Meanwhile BBCA +3.06% on Rp747bn is absorbing the flow. That's defensive money hiding in one bank, not broad participation. Breadth ran 801–824 counters traded; the gainers list is dominated by illiquid micro-caps (XCIS +14.7% on 22 lots, MKNT on 18,247 lots) — classic thin-tape speculation, not conviction.

The one genuinely relevant read-across: OILS (Indo Oil Perkasa) −6.81% was among the top losers on Rp1.16bn value. CEKA (Wilmar Cahaya Indonesia) is a refined edible oils / palm derivative producer, so OILS is about as close to a listed comp as the board offers. Sympathy selling in the refined-oils complex on a soft tape is a negative prior — but it is a prior, not evidence about CEKA specifically.

Sector dispersion is high. ANTM +1.8% and TPIA +0.73% held green while BRPT −6.04% and ENRG −6.54% sold off hard. Commodity-linked names are trading on their own stories right now, which cuts both ways: it means OILS' weakness may not transmit to CEKA at all.

What I'd need before forming a view

1. A quote — last, change, VWAP vs. close, and lot volume. Without VWAP-vs-price I can't tell accumulation from distribution.
2. Recent filings/news — CEKA is a low-coverage small cap; the real catalysts are monthly CPO/downstream margin disclosures and quarterly reports, not wire stories. An absence of Yahoo headlines is normal here and says nothing bad.
3. CPO reference price — the single dominant driver of refined edible-oil margins. Not in my available data.
4. Its own technical structure — the screener's buckets (BLES in KONFLIK DISTRIBUSI at 59.4% win rate; IMPC in AKUMULASI SENYAP) show the framework screens for volume-vs-price conflict and silent accumulation. CEKA triggering neither is mildly informative but no more than that.

Practical stance

No trade recommendation. CEKA isn't in a state I can assess — and note that "not in the screener" is not a bearish signal, it's an absence of signal.

If you're already positioned or considering it: the tape argues for patience rather than chasing. Liquid leaders are distributing, the only oils comp is down ~7%, and gainers are micro-cap noise. That's a backdrop where a thin small-cap gets hit disproportionately on any seller. Wait for a real quote and a volume print before acting.

Want me to re-run once market data is back, or dig into OILS and the broader plant-based/edible oils names as a proxy read?